Evidence map›Paper›PMID 41071564›Full record

ReviewEpilepsia open2025

Seizures beget more than seizures: Understanding the cellular, structural, individual and societal impact of seizures in epilepsy.

Matthew C Walker, Marian Galovic, Elena Álvarez-Barón, Adam Strzelczyk

Abstract readReview
In one paragraph

Review in Epilepsia open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew C WalkerDepartment of Clinical Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.ORCID https://orcid.org/0000-0002-0812-0352
Marian GalovicDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Elena Álvarez-BarónAngelini Pharma, Barcelona, Spain.
Adam StrzelczykEpilepsy Center Frankfurt Rhine-Main, Department of Neurology, Goethe-University Frankfurt, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0001-6288-9915

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is primarily defined by the repetitive occurrence of seizures, but the full impact of seizures extends beyond these episodic events. Seizures themselves cause changes at the cellular, network, and systemic levels in individual patients with epilepsy and may contribute to the progressive nature of the disease in some patients. Seizures may have an impact on brain structure and function over time. There is also a high societal and economic burden associated with persistent seizures, including major impacts on quality of life, activities of daily living, and productivity. Therefore, seizure freedom with no or minimal side effects should be the key goal in the treatment of epilepsy, with the potential to reduce both disease progression and the societal and economic impacts of the disease. Physicians have a responsibility to address the key obstacles to early seizure freedom, including optimizing initial treatment strategies, minimizing treatment delays, overcoming therapeutic nihilism, and improving medication adherence. PLAIN LANGUAGE SUMMARY: Epilepsy involves repeated seizures which can cause changes in the brain over time and affect memory, thoughts, and everyday activities. Repeated seizures place a heavy burden on individuals, families, and society, affecting their quality of life, independence, and work. The main goal of epilepsy treatment should be the elimination of all seizures with few or no side effects. To achieve this, doctors should act quickly, choose the right treatments early, avoid treatment delays, and support patients in taking their medications.

Indexed as

BrainCost of IllnessEpilepsySeizuresHumansQuality of Lifeantiseizure medicationsepilepsyinflammationquality of lifeseizure

Identifiers

PMID41071564
PMCPMC12716293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.